Literature DB >> 24337141

The small GTPase RhoA regulates the expression and function of the sodium channel Nav1.5 in breast cancer cells.

C Dulong1, Y J Fang2, C Gest1, M H Zhou2, C Patte-Mensah3, A G Mensah-Nyagan3, J P Vannier1, H Lu4, C Soria1, L Cazin1, Y A Mei2, R Varin1, H Li1.   

Abstract

Voltage-gated Na+ channels (VGSCs) are highly expressed in several types of carcinomas including breast, prostate and lung cancers as well as in mesothelioma and cervical cancers. Although the VGSCs activity is considered crucial for the potentiation of cancer cell migration and invasion, the mechanisms responsible for their functional expression and regulation in cancer cells remain unclear. In the present study, the role of the small GTPase RhoA in the regulation of expression and function of the Nav1.5 channel in the breast cancer cell lines MDA-MB 231 and MCF-7 was investigated. RhoA silencing significantly reduced both Nav1.5 channel expression and sodium current indicating that RhoA exerts a stimulatory effect on the synthesis of an active form of Nav1.5 channel in cancer cells. The inhibition of Nav1.5 expression dramatically reduced both cell invasion and proliferation. In addition, a decrease of RhoA protein levels induced by Nav1.5 silencing was observed. Altogether, these findings revealed: i) the key role of the small GTPase RhoA in upregulation of Nav1.5 channel expression and tumor aggressiveness, and ii) the existence of a positive feedback of Nav1.5 channels on RhoA protein levels.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24337141     DOI: 10.3892/ijo.2013.2214

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  9 in total

1.  Small G-protein RhoA is a potential inhibitor of cardiac fast sodium current.

Authors:  Denis V Abramochkin; Tatiana S Filatova; Ksenia B Pustovit; Irina Dzhumaniiazova; Alexey V Karpushev
Journal:  J Physiol Biochem       Date:  2020-11-04       Impact factor: 4.158

Review 2.  Discovering the Triad between Nav1.5, Breast Cancer, and the Immune System: A Fundamental Review and Future Perspectives.

Authors:  Harishini Rajaratinam; Noor Fatmawati Mokhtar; Nurul Asma-Abdullah; Wan Ezumi Mohd Fuad
Journal:  Biomolecules       Date:  2022-02-15

3.  RhoA activity increased in myocardium of arrhythmogenic cardiomyopathy patients and affected connexin 43 protein expression in HL-1 cells.

Authors:  Li Wang; Shenghua Liu; Hongliang Zhang; Shengshou Hu; Yingjie Wei
Journal:  Int J Clin Exp Med       Date:  2015-08-15

4.  MicroRNA-146a inhibits cell migration and invasion by targeting RhoA in breast cancer.

Authors:  Qin Liu; Wei Wang; Xiongfa Yang; Dongxiao Zhao; Fangqiong Li; Hai Wang
Journal:  Oncol Rep       Date:  2016-05-06       Impact factor: 3.906

Review 5.  Voltage-gated sodium channel as a target for metastatic risk reduction with re-purposed drugs.

Authors:  Tomas Koltai
Journal:  F1000Res       Date:  2015-07-22

6.  Expression of voltage-gated sodium channel Nav1.5 in non-metastatic colon cancer and its associations with estrogen receptor (ER)-β expression and clinical outcomes.

Authors:  Jianhong Peng; Qingjian Ou; Xiaojun Wu; Rongxin Zhang; Qian Zhao; Wu Jiang; Zhenhai Lu; Desen Wan; Zhizhong Pan; Yujing Fang
Journal:  Chin J Cancer       Date:  2017-11-09

7.  Reduced gamma oscillations in a mouse model of intellectual disability: a role for impaired repetitive neurotransmission?

Authors:  Andrew D Powell; Pierre-Philippe Saintot; Kalbinder K Gill; Ashtami Bharathan; S Caroline Buck; Gareth Morris; Premysl Jiruska; John G R Jefferys
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

8.  Multiple Nav1.5 isoforms are functionally expressed in the brain and present distinct expression patterns compared with cardiac Nav1.5.

Authors:  Jun Wang; Shao-Wu Ou; Yun-Fei Bai; Yun-Jie Wang; Zhi-Qing David Xu; Guo-Ming Luan
Journal:  Mol Med Rep       Date:  2017-05-30       Impact factor: 2.952

9.  Rock inhibition promotes NaV1.5 sodium channel-dependent SW620 colon cancer cell invasiveness.

Authors:  Lucile Poisson; Osbaldo Lopez-Charcas; Pierre Besson; Sébastien Roger; Driffa Moussata; Stéphanie Chadet; Emeline Bon; Roxane Lemoine; Lucie Brisson; Mehdi Ouaissi; Christophe Baron
Journal:  Sci Rep       Date:  2020-08-07       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.